Navigation Links
JeanMarie Houghton, MD, PhD, recognized as one of nation's top young scientists
Date:11/1/2007

WORCESTER, Mass. University of Massachusetts Medical School Associate Professor of Medicine and Cancer Biology JeanMarie Houghton, MD, PhD, was recognized today as one of the countrys most talented rising scientific stars in a White House ceremony applauding the 2006 recipients of the Presidential Early Career Award for Scientists and Engineers (PECASE) Awards. The Presidential Award is the highest honor bestowed by the U.S. government on outstanding scientists and engineers beginning their independent careers. Granted to a select group of professionals each year, the awards are intended to recognize and nurture some of the finest scientists and engineers who, while early in their research careers, show exceptional potential for leadership at the frontiers of scientific knowledge during the twenty-first century.

I am absolutely astounded and feel very fortunate to have been chosen for this award, said Dr. Houghton. It is such a meaningful validation of our work to have our ideas and ambitions recognized at the national level. It demonstrates the faith the government and the National Institutes of Health puts not only in the work of my lab but also in the Medical School as a whole, affirming that this is the right kind of work happening at the right place.

"The outstanding and innovative work of Dr. Houghton demonstrates how young physician-scientists can make breakthrough discoveries by asking the right questions. We are very fortunate and very proud to have her as a member of our team," said Terry R. Flotte, MD, executive deputy chancellor of UMMS and dean of the School of Medicine

A member of the Medical School faculty since 2001, Houghton is broadly interested in the contribution of stem cells to cancer. In 2004, Houghton and colleagues published stunning findings in Science that provided a radically different view of the origins of gastric cancers, identifying an unexpected link between stomach cancer and bone marrow-derived stem cells. The investigators discovered that infection with Helicobacter felis (a bacterium related to Helicobacter plyori, which has long been understood to cause chronic inflammation and cancer in the lining of the stomach) leads to a vast influx of bone marrow-derived stem cells as the body tries to repair the damage caused by the bacterial infection. Houghton and collaborators showed that this flood of bone marrow-derived stem cells can actually lead to the development of stomach cancer.

The PECASE Award was granted based upon the strength of a recent research proposal that builds upon these findings. With the funding support associated with the honor, Houghton aims to further understand the progression of events that leads to the dire consequence of an influx of stem cells. Specifically, the Houghton lab will study the signaling mechanisms that direct the stem cells actions with the ultimate goal of intervention to coax the cells to differentiate normally, or for those cells that have already metastasized, to develop more targeted treatments that spare healthy cells the detrimental effect of current chemotherapies.

This award is not only extraordinary prestigious and a unique personal achievement, but is also a most compelling recognition of how Dr. Houghtons work was a catalyst to bringing together so many fields of research and conceptualizing a ground-breaking discovery pivotal for the understanding of human diseases, said Dario C. Altieri, MD, the Eleanor Eustis Farrington Chair in Cancer Research and professor and chair of cancer biology.

Instituted in 1996, the PECASE Awards embody the high priority placed by the government on maintaining the United States leadership position in science by producing outstanding scientists and engineers who will broadly advance science and the missions important to the participating agencies, which include the National Science Foundation, National Science and Technology Council, National Aeronautics and Space Administration, Environmental Protection Agency, Department of Agriculture, Department of Commerce, Department of Defense, Department of Energy, Department of Health and Human Services, Department of Transportation and the Department of Veterans Affairs. Houghton is just the second UMass Medical School PECASE Award recipient. In 2005, Assistant Professor of Medicine Neal S. Silverman, PhD, was recognized with the award for his research into the mechanisms controlling innate immunity.

Dr. Houghtons achievements demonstrate the important role played by clinician-scientist; investigators who are able to take care of patents while pursuing ground breaking research studies, Her observation that normal stem cells that migrate to an area of chronic infection can develop into cancer cells, has already had a major impact on our thinking about the nature of the development of cancer. Her studies on the plasticity of stem cells and the effect of the environment will lead to new approaches to preventing and treating cancer in the near future, said UMMS Chair of Medicine Robert W. Finberg, MD, the Richard M. Haidack Professor of Medicine.


'/>"/>

Contact: Kelly Bishop
kelly.bishop@umassmed.edu
508-856-2000
University of Massachusetts Medical School  
Source:Eurekalert

Related medicine news :

1. Time magazine has recognized efforts of two Indian doctors towards reducing infant mortality rate
2. Nurse Practitioners Are Not Recognized By Medicare
3. Scientist Recognized for Drug Addiction Research
4. Medical Center Recognized for Excellence in Bariatric Surgery
5. A young scientist recognized for biomechanics innovations
6. Distinguishable Traits of Fatal Skin Cancer Recognized
7. Bipolar Spectrum Disorder may Be Under-recognized for Spectrum Disorder: Study
8. Roche offers HIV drug expertise to poor nations
9. Drug Combinations May Boost Stroke Risk
10. The Link Between Childhood Vaccinations And Diabetes Questioned
11. Research finds new explanations for dyslexia
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
JeanMarie Houghton, MD, PhD, recognized as one of nation's top young scientists
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)...  In a startling report released today, National Safety Council ... a comprehensive, proven plan to eliminate prescription opioid overdoses. ... states are tackling the worst drug crisis in recorded U.S. history, ... Kentucky , New Mexico , ... the 28 failing states, three – Michigan , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: